ID

116

Beschrijving

ODM derived from http://clinicaltrials.gov/ct2/show/record/NCT01428297

Link

http://clinicaltrials.gov/ct2/show/record/NCT01428297

Trefwoorden

  1. 25-11-11 25-11-11 -
  2. 04-06-17 04-06-17 - Martin Dugas
Geüploaded op

25 november 2011

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY-NC 3.0 Legacy

Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility NCT01428297 Atopic Dermatitis

Eligibility

  1. StudyEvent: Eligibility
    1. Eligibility
Inclusion Criteria Healthy volunteers
Beschrijving

Inclusion Criteria Healthy volunteers

Healthy male and female subjects of non childbearing potential, 18 to 65 years of age inclusive and in good health
Beschrijving

Healthy volunteers 18-65 years

Datatype

boolean

Inclusion Criteria Patients with atopic dermatitis
Beschrijving

Inclusion Criteria Patients with atopic dermatitis

Male and female subjects, 18 to 65 years of age inclusive and having passed screening examinations
Beschrijving

Age 18-65

Datatype

boolean

Presence of atopic dermatitis confirmed by Itchy skin condition in the past 12 months (must have) Plus three or more of the following: 1. History of involvement of the skin creases 2. Personal history of asthma or hay fever 3. History of generally dry skin in the past year 4. Onset before age of 2 years 5. Visible flexural dermatitis
Beschrijving

Atopic Dermatitis

Datatype

boolean

Diagnosis of at least moderate atopic dermatitis by the IGA and a minimum target area (right or left) situated on the forearm including the antecubital fossa with a corresponding baseline total lesional sign score (TLSS)
Beschrijving

At least moderate atopic dermatitis

Datatype

boolean

Inclusion Criteria Patients with Netherton Syndrome
Beschrijving

Inclusion Criteria Patients with Netherton Syndrome

Patients with Netherton syndrome, male and female subjects, 18 to 65 years of age inclusive and having passed screening examinations
Beschrijving

Netherton syndrom, Age 18-65 Years

Datatype

boolean

Confirmed diagnosis of Netherton syndrome (SPINK5 mutation or LEKTI deficiency in the skin)
Beschrijving

confirmed Netherton syndrome

Datatype

boolean

Minimum total lesional sign score NS (TLSS-NS) of 5-9 for two selected target areas at baseline. The TLSS-NS values need to be similar between the two areas at baseline
Beschrijving

Total lesional sign score

Datatype

boolean

Exclusion Criteria Healthy volunteers
Beschrijving

Exclusion Criteria Healthy volunteers

History of hypersensitivity to any of the study drugs or to drugs of similar chemical classes or history of serious allergic reaction.
Beschrijving

Allergy to study drug

Datatype

boolean

Use of any prescription drugs, herbal supplements, within four (4) weeks prior to initial dosing, and/or over-the-counter (OTC) medication, dietary supplements (vitamins included) within two (2) weeks prior to initial dosing
Beschrijving

Other drugs

Datatype

boolean

Exclusion Criteria Patients with atopic dermatitis
Beschrijving

Exclusion Criteria Patients with atopic dermatitis

History of hypersensitivity to any of the study drugs or to drugs of similar chemical classes or history of serious allergic reaction.
Beschrijving

Allergy to study drug

Datatype

boolean

History of abnormal skin reactivity to UV light. Unusual exposure to UV light in the previous 3 weeks to study start (screening), including tanning and sun beds
Beschrijving

Skin reactivity to UV

Datatype

boolean

Pregnant or nursing (lactating) women
Beschrijving

Pregnancy, Lactation

Datatype

boolean

Women of child-bearing potential must use highly effective contraception (as further defined in study protocol)
Beschrijving

Contraception

Datatype

boolean

Use of topical prescription treatment for eczema within 1 week prior to initial dosing of topical corticosteroids (TCS).
Beschrijving

Topical eczema treatment

Datatype

boolean

Recent previous treatment with systemic treatment including phototherapy. A washout period will be required for such patients to be eligible to participate in the trial.
Beschrijving

Recent systemic treatment for atopic dermatitis

Datatype

boolean

Exclusion Criteria Patients with Netherton Syndrome
Beschrijving

Exclusion Criteria Patients with Netherton Syndrome

History of hypersensitivity to any of the study drugs or to drugs of similar chemical classes or history of serious allergic reaction
Beschrijving

Allergy to study drug

Datatype

boolean

History of abnormal skin reactivity to UV light. Unusual exposure to UV light in the previous 3 weeks to study start (screening), including tanning and sun beds
Beschrijving

Skin reactivity to UV

Datatype

boolean

Pregnant or nursing (lactating) women
Beschrijving

Pregnancy, Lactation

Datatype

boolean

Women of child-bearing potential must use highly effective contraception (as further defined in study protocol)
Beschrijving

Contraception

Datatype

boolean

Use of topical prescription treatment within 2 week prior to initial dosing of study drug
Beschrijving

Topical prescription treatment

Datatype

boolean

Recent previous treatment with systemic treatment. A washout period will be required for such patients to be eligible to participate in the trial.
Beschrijving

Recent systemic treatment

Datatype

boolean

Medical Concepts
Beschrijving

Medical Concepts

Age
Beschrijving

Age

Datatype

string

Alias
UMLS CUI
C0001779
SNOMED CT 2010_0731
102518004
Healthy Subject
Beschrijving

Healthy Volunteer

Datatype

string

Alias
UMLS CUI
C1708335
Diagnosis
Beschrijving

Diagnosis

Datatype

string

Alias
UMLS CUI
C0011900
SNOMED CT 2010_0731
439401001
LOINC Version 232
MTHU008876
Dermatitis, Atopic
Beschrijving

Atopic eczema

Datatype

string

Alias
UMLS CUI
C0011615
SNOMED CT 2010_0731
24079001
MedDRA 13.1
10012434
ICD-10-CM Version 2010
L20
Pruritus
Beschrijving

Itchy skin

Datatype

string

Alias
UMLS CUI
C0033774
SNOMED CT 2010_0731
418363000
MedDRA 13.1
10037087
ICD-10-CM Version 2010
L29
ICD-9-CM Version 2011
698.9
CTCAE Version 4.03
E13686
Skin crease
Beschrijving

Skin crease

Datatype

string

Alias
UMLS CUI
C0459397
SNOMED CT 2010_0731
280385004
Asthma
Beschrijving

Bronchial Asthma

Datatype

string

Alias
UMLS CUI
C0004096
SNOMED CT 2010_0731
195967001
MedDRA 13.1
10003553
LOINC Version 232
MTHU020815
ICD-10-CM Version 2010
J45
ICD-9-CM Version 2011
493
Hay fever (Seasonal Allergy)
Beschrijving

Allergic rhinitis due to pollen

Datatype

string

Alias
UMLS CUI
C0018621
SNOMED CT 2010_0731
367498001
MedDRA 13.1
10048908
ICD-10-CM Version 2010
J30.1
ICD-9-CM Version 2011
477.0
Dry skin
Beschrijving

Dry skin

Datatype

string

Alias
UMLS CUI
C0151908
SNOMED CT 2010_0731
16386004
MedDRA 13.1
10013786
CTCAE Version 4.03
E13623
Onset
Beschrijving

Onset

Datatype

string

Alias
UMLS CUI
C0332162
SNOMED CT 2010_0731
77374008
Flexural eczema
Beschrijving

Flexural atopic dermatitis

Datatype

string

Alias
UMLS CUI
C0263224
SNOMED CT 2010_0731
402183009
MedDRA 13.1
10016775
ICD-10-CM Version 2010
L20.82
Allergic reaction, due to correct medicinal substance properly administered
Beschrijving

Allergic reaction, due to correct medicinal substance properly administered

Datatype

string

Alias
UMLS CUI
C0274302
SNOMED CT 2010_0731
57302007
Medication
Beschrijving

Pharmaceutical Preparations

Datatype

string

Alias
UMLS CUI
C0013227
Dietary Supplements
Beschrijving

Nutritional supplement

Datatype

string

Alias
UMLS CUI
C0242295
SNOMED CT 2010_0731
108961000
LOINC Version 232
MTHU035664
Ultraviolet Rays
Beschrijving

UV

Datatype

string

Alias
UMLS CUI
C0041625
SNOMED CT 2010_0731
41355003
pregnant
Beschrijving

pregnant

Datatype

string

Alias
UMLS CUI
C0549206
MedDRA 13.1
10036586
Breast feeding, Nursing
Beschrijving

Lactation

Datatype

string

Alias
UMLS CUI
C0006147
MedDRA 13.1
10006247
Contraception
Beschrijving

Contraception

Datatype

string

Alias
UMLS CUI
C0700589
SNOMED CT 2010_0731
146680009
MedDRA 13.1
10010808
Topical Corticosteroid
Beschrijving

Topical Corticosteroid

Datatype

string

Alias
UMLS CUI
C0304604
SNOMED CT 2010_0731
331645009
Phototherapy
Beschrijving

Light therapy

Datatype

string

Alias
UMLS CUI
C0031765
SNOMED CT 2010_0731
31394004
MedDRA 13.1
10063925

Similar models

Eligibility

  1. StudyEvent: Eligibility
    1. Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
Inclusion Criteria Healthy volunteers
Healthy volunteers 18-65 years
Item
Healthy male and female subjects of non childbearing potential, 18 to 65 years of age inclusive and in good health
boolean
Item Group
Inclusion Criteria Patients with atopic dermatitis
Age 18-65
Item
Male and female subjects, 18 to 65 years of age inclusive and having passed screening examinations
boolean
Atopic Dermatitis
Item
Presence of atopic dermatitis confirmed by Itchy skin condition in the past 12 months (must have) Plus three or more of the following: 1. History of involvement of the skin creases 2. Personal history of asthma or hay fever 3. History of generally dry skin in the past year 4. Onset before age of 2 years 5. Visible flexural dermatitis
boolean
At least moderate atopic dermatitis
Item
Diagnosis of at least moderate atopic dermatitis by the IGA and a minimum target area (right or left) situated on the forearm including the antecubital fossa with a corresponding baseline total lesional sign score (TLSS)
boolean
Item Group
Inclusion Criteria Patients with Netherton Syndrome
Netherton syndrom, Age 18-65 Years
Item
Patients with Netherton syndrome, male and female subjects, 18 to 65 years of age inclusive and having passed screening examinations
boolean
confirmed Netherton syndrome
Item
Confirmed diagnosis of Netherton syndrome (SPINK5 mutation or LEKTI deficiency in the skin)
boolean
Total lesional sign score
Item
Minimum total lesional sign score NS (TLSS-NS) of 5-9 for two selected target areas at baseline. The TLSS-NS values need to be similar between the two areas at baseline
boolean
Item Group
Exclusion Criteria Healthy volunteers
Allergy to study drug
Item
History of hypersensitivity to any of the study drugs or to drugs of similar chemical classes or history of serious allergic reaction.
boolean
Other drugs
Item
Use of any prescription drugs, herbal supplements, within four (4) weeks prior to initial dosing, and/or over-the-counter (OTC) medication, dietary supplements (vitamins included) within two (2) weeks prior to initial dosing
boolean
Item Group
Exclusion Criteria Patients with atopic dermatitis
Allergy to study drug
Item
History of hypersensitivity to any of the study drugs or to drugs of similar chemical classes or history of serious allergic reaction.
boolean
Skin reactivity to UV
Item
History of abnormal skin reactivity to UV light. Unusual exposure to UV light in the previous 3 weeks to study start (screening), including tanning and sun beds
boolean
Pregnancy, Lactation
Item
Pregnant or nursing (lactating) women
boolean
Contraception
Item
Women of child-bearing potential must use highly effective contraception (as further defined in study protocol)
boolean
Topical eczema treatment
Item
Use of topical prescription treatment for eczema within 1 week prior to initial dosing of topical corticosteroids (TCS).
boolean
Recent systemic treatment for atopic dermatitis
Item
Recent previous treatment with systemic treatment including phototherapy. A washout period will be required for such patients to be eligible to participate in the trial.
boolean
Item Group
Exclusion Criteria Patients with Netherton Syndrome
Allergy to study drug
Item
History of hypersensitivity to any of the study drugs or to drugs of similar chemical classes or history of serious allergic reaction
boolean
Skin reactivity to UV
Item
History of abnormal skin reactivity to UV light. Unusual exposure to UV light in the previous 3 weeks to study start (screening), including tanning and sun beds
boolean
Pregnancy, Lactation
Item
Pregnant or nursing (lactating) women
boolean
Contraception
Item
Women of child-bearing potential must use highly effective contraception (as further defined in study protocol)
boolean
Topical prescription treatment
Item
Use of topical prescription treatment within 2 week prior to initial dosing of study drug
boolean
Recent systemic treatment
Item
Recent previous treatment with systemic treatment. A washout period will be required for such patients to be eligible to participate in the trial.
boolean
Item Group
Medical Concepts
Age
Item
Age
string
C0001779 (UMLS CUI)
102518004 (SNOMED CT 2010_0731)
Healthy Volunteer
Item
Healthy Subject
string
C1708335 (UMLS CUI)
Diagnosis
Item
Diagnosis
string
C0011900 (UMLS CUI)
439401001 (SNOMED CT 2010_0731)
MTHU008876 (LOINC Version 232)
Atopic eczema
Item
Dermatitis, Atopic
string
C0011615 (UMLS CUI)
24079001 (SNOMED CT 2010_0731)
10012434 (MedDRA 13.1)
L20 (ICD-10-CM Version 2010)
Itchy skin
Item
Pruritus
string
C0033774 (UMLS CUI)
418363000 (SNOMED CT 2010_0731)
10037087 (MedDRA 13.1)
L29 (ICD-10-CM Version 2010)
698.9 (ICD-9-CM Version 2011)
E13686 (CTCAE Version 4.03)
Skin crease
Item
Skin crease
string
C0459397 (UMLS CUI)
280385004 (SNOMED CT 2010_0731)
Bronchial Asthma
Item
Asthma
string
C0004096 (UMLS CUI)
195967001 (SNOMED CT 2010_0731)
10003553 (MedDRA 13.1)
MTHU020815 (LOINC Version 232)
J45 (ICD-10-CM Version 2010)
493 (ICD-9-CM Version 2011)
Allergic rhinitis due to pollen
Item
Hay fever (Seasonal Allergy)
string
C0018621 (UMLS CUI)
367498001 (SNOMED CT 2010_0731)
10048908 (MedDRA 13.1)
J30.1 (ICD-10-CM Version 2010)
477.0 (ICD-9-CM Version 2011)
Dry skin
Item
Dry skin
string
C0151908 (UMLS CUI)
16386004 (SNOMED CT 2010_0731)
10013786 (MedDRA 13.1)
E13623 (CTCAE Version 4.03)
Onset
Item
Onset
string
C0332162 (UMLS CUI)
77374008 (SNOMED CT 2010_0731)
Flexural atopic dermatitis
Item
Flexural eczema
string
C0263224 (UMLS CUI)
402183009 (SNOMED CT 2010_0731)
10016775 (MedDRA 13.1)
L20.82 (ICD-10-CM Version 2010)
Allergic reaction, due to correct medicinal substance properly administered
Item
Allergic reaction, due to correct medicinal substance properly administered
string
C0274302 (UMLS CUI)
57302007 (SNOMED CT 2010_0731)
Pharmaceutical Preparations
Item
Medication
string
C0013227 (UMLS CUI)
Nutritional supplement
Item
Dietary Supplements
string
C0242295 (UMLS CUI)
108961000 (SNOMED CT 2010_0731)
MTHU035664 (LOINC Version 232)
UV
Item
Ultraviolet Rays
string
C0041625 (UMLS CUI)
41355003 (SNOMED CT 2010_0731)
pregnant
Item
pregnant
string
C0549206 (UMLS CUI)
10036586 (MedDRA 13.1)
Lactation
Item
Breast feeding, Nursing
string
C0006147 (UMLS CUI)
10006247 (MedDRA 13.1)
Contraception
Item
Contraception
string
C0700589 (UMLS CUI)
146680009 (SNOMED CT 2010_0731)
10010808 (MedDRA 13.1)
Topical Corticosteroid
Item
Topical Corticosteroid
string
C0304604 (UMLS CUI)
331645009 (SNOMED CT 2010_0731)
Light therapy
Item
Phototherapy
string
C0031765 (UMLS CUI)
31394004 (SNOMED CT 2010_0731)
10063925 (MedDRA 13.1)

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial